PregLem Company

PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine.
Industry: Reproductive Health & Contraception
Headquarters: Geneva, Geneve, Switzerland
Founded Date: 01-01-2006
Employees Number: 11-50
Funding Status: M&A
Investors Number: 4
Total Funding: $58,248,124
Last Funding Date: 2007-12-04
Last Funding Type: Series B

Visit Website
Register and Claim Ownership